Cumulative treatment outcomes prevalence rates for patients in ART treatment from year 2020 to 2022 for study participant in Bauchi State. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis for LTFU according to Viral Load status and BMI status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Demographic characteristics of study participants from two ART facilities in Bauchi state, based on data retrieved covering a three-year period from 2020 to 2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Annual incidence rate per 100 person-years trend for ART treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Authority Groups. by David Vagni (8060432)

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Clarity Groups. by David Vagni (8060432)

The mean unfed body weight of uninfected <i>Rhodnius prolixus</i> at different developmental stages and ambient temperatures. by Henri Loshouarn (17896676)

The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

Subjects:

Most significant muscle activation values. by María Benito-de-Pedro (22057468)

Subjects:

Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

Subjects:

MWM training data. by Robert Botelho (20308297)

Subjects:

Longitudinal assessment of animal weights and tumor metrics. by Robert Botelho (20308297)

Subjects:

Spatial exploration patterns of tumor bearing mice under different treatment conditions in the Morris Water Maze (MWM). by Robert Botelho (20308297)

Subjects:

Spatial exploration patterns of non-tumor bearing mice under different treatment conditions in the Morris Water Maze (MWM). by Robert Botelho (20308297)

Subjects:

Results from linear regression analysis for δ¹³C or δ¹⁵N and collection date. by Nathan D. McTigue (10706460)

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Subjects:

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

Subjects:

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Subjects:

Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

Subjects: